HomeCompareNEPT vs GBDC

NEPT vs GBDC: Dividend Comparison 2026

NEPT yields 1000.00% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEPT wins by $18844417.83M in total portfolio value
10 years
NEPT
NEPT
● Live price
1000.00%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18844438.68M
Annual income
$15,746,803,993,532.36
Full NEPT calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — NEPT vs GBDC

📍 NEPT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEPTGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEPT + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEPT pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEPT
Annual income on $10K today (after 15% tax)
$85,000.00/yr
After 10yr DRIP, annual income (after tax)
$13,384,783,394,502.51/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, NEPT beats the other by $13,384,769,411,378.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEPT + GBDC for your $10,000?

NEPT: 50%GBDC: 50%
100% GBDC50/50100% NEPT
Portfolio after 10yr
$9422229.76M
Annual income
$7,873,410,222,133.10/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

NEPT
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-5971.0
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEPT buys
0
GBDC buys
0
No recent congressional trades found for NEPT or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEPTGBDC
Forward yield1000.00%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$18844438.68M$20.85M
Annual income after 10y$15,746,803,993,532.36$16,450,733.83
Total dividends collected$18607754.73M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: NEPT vs GBDC ($10,000, DRIP)

YearNEPT PortfolioNEPT Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$110,700$100,000.00$12,492$1,791.70+$98.2KNEPT
2$1,153,028$1,034,579.44$16,527$3,160.58+$1.14MNEPT
3$11,304,737$10,070,996.94$23,588$5,904.90+$11.28MNEPT
4$104,376,400$92,280,331.11$37,141$11,901.65+$104.34MNEPT
5$907,965,307$796,282,558.81$66,205$26,463.38+$907.90MNEPT
6$7,445,190,031$6,473,667,152.78$137,452$66,612.65+$7445.05MNEPT
7$57,576,798,154$49,610,444,821.11$342,372$195,298.53+$57576.46MNEPT
8$420,166,535,918$358,559,361,892.40$1,053,292$686,954.33+$420165.48MNEPT
9$2,894,985,686,808$2,445,407,493,376.48$4,111,439$2,984,416.95+$2894981.58MNEPT
10$18,844,438,678,417$15,746,803,993,532.36$20,849,974$16,450,733.83+$18844417.83MNEPT

NEPT vs GBDC: Complete Analysis 2026

NEPTStock

Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.

Full NEPT Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this NEPT vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEPT vs SCHDNEPT vs JEPINEPT vs ONEPT vs KONEPT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.